Showing posts with label 2009. Show all posts
Showing posts with label 2009. Show all posts

Wednesday, August 29, 2012

Study: Kids, Underlying Conditions, And The 2009 Pandemic Flu

image

Credit CDC FluView

 

# 6522

 

The chart above illustrates the sharp rise in pediatric deaths from flu-related complications during the 2009-2010 H1N1 pandemic seasons in the United States.  As grim as this charts is, it probably doesn’t fully represent the burden the 2009 pandemic placed on the pediatric community.

 

In another chart, again from the CDC, we get an estimate of deaths related to the 2009 pandemic, broken down by age groups through April of 2010.

 

image

 

While just over 300 pediatric deaths were recorded during this time period, the CDC estimates that 4 times (n=1280) that many children likely died from flu-related illness in the United States.

 

Globally, the number was undoubtedly many times higher than that (see Lancet: Estimating Global 2009 Pandemic Mortality).

 

 

All of which serves as prelude to a new study that appears today in the journal  Pediatrics, that looks at 336 documented pH1N1-associated deaths, and finds a high number of kids with underlying neurologic conditions.

 

Two-thirds of all deaths in children under the age of 17 occurred in kids with at least 1 underlying medical condition (n=227), and just under half of all cases (n=146) involved neurological disorders, such as cerebral palsy, epilepsy, or intellectual disability.

 

 

Neurologic Disorders Among Pediatric Deaths Associated With the 2009 Pandemic Influenza

Lenee Blanton, MPHa,Georgina Peacock, MD, MPH, FAAPb, Chad Cox, MD, MPHa, Michael Jhung, MD, MPHa, Lyn Finelli, DrPHa, and Cynthia Moore, MD, PhDb

ABSTRACT (Excerpts)

RESULTS: Of 336 pH1N1-associated pediatric deaths with information on underlying conditions, 227 (68%) children had at least 1 underlying condition that conferred an increased risk of complications of influenza. Neurologic disorders were most frequently reported (146 of 227 [64%]), and, of those disorders, neurodevelopmental disorders such as cerebral palsy and intellectual disability were most common.

CONCLUSIONS: Neurologic disorders were reported in nearly two-thirds of pH1N1-associated pediatric deaths with an underlying medical condition. Because of the potential for severe outcomes, children with underlying neurologic disorders should receive influenza vaccine and be treated early and aggressively if they develop influenza-like illness.

 

According to a statement released last night by the CDC:

 

Of the children with neurologic disorders for whom information on vaccination status was available, only 21 (23 percent) had received the seasonal influenza vaccine and 2 (3 percent) were fully vaccinated for 2009 H1N1.

 

 

With September just around the corner, the annual push for flu vaccinations is upon us, and today’s study will hopefully help inspire parents to get all kids – regardless of underlying conditions - vaccinated against influenza.

 

While the effectiveness of flu vaccines vary from year-to-year, and indeed, from one person to the next, they remain the single most important preventative step you can take to avoid getting the flu each year.

 

Despite the hyperbolic anti-vaccine rhetoric often found on the Internet, the truth is, serious adverse reactions to the vaccine are exceedingly rare (see the CDC’s  Influenza Vaccine Safety).

 

With two new strains of seasonal flu expected to be in circulation this winter (Yamagata B, and the Victoria H3N2) ones that will be covered by this year’s vaccine – getting the flu shot this year is doubly important.

 

CDC recommends that just about everyone aged 6 months and older get an annual influenza vaccination, and stresses their importance for those who are at greater risk of serious complications.

 

For more on vaccine safety and effectiveness, the CDC maintains extensive web pages, and resources, on seasonal flu vaccines, including:

 

What You Should Know for the 2012-2013 Influenza Season

 

Preventing Seasonal Flu With Vaccination

 

Children, the Flu, and the Flu Vaccine

Tuesday, June 26, 2012

Lancet: Estimating Global 2009 Pandemic Mortality

 

 

# 6505

 

 

Sounding a bit like a broken record, during the first 12 months of the 2009 pandemic I wrote repeatedly on our inability to accurate count – or even estimate – the number of H1N1 flu deaths in the United States and around the globe.

 

Just a few of those posts include:

 

Dead Reckoning
The Tip Of The Iceberg
When No Number Is Right
Apples, Oranges, And Influenza Death Tolls

 

The CFR, or case fatality ratio is generally seen as the most important statistic in any pandemic, and yet it is often the hardest to quantify. This number is the percentage of people who, once infected, die (either directly or indirectly) as a result of that infection.

 

While that may seem a simple enough task , the truth is that even during a `normal’ flu season the CDC can only estimate the number of deaths in the United States related to influenza.

 

The problem is, influenza can provoke or exacerbate many other medical problems. Influenza can obviously lead to pneumonia and death, but it has also been linked to heart attacks, strokes (CVAs), and other potentially fatal health crises.

   

Most of the time, the attending doctor signs the death certificate and puts down the most immediate or obvious cause of death.  If influenza was a factor, it rarely is noticed or noted.

 

The official numbers we get from the CDC, the World Health Organization, and from individual countries are almost always referred to as `the tip of the iceberg’, or as in the graphic below, the tip of the pyramid.

 

surveillance

 

And this is the best we can do in developed countries, where the majority of people have at least some access to medical care and where governments make an attempt to maintain public health records and death registries.

 

For much of the rest of the world, these are luxuries that are too often unavailable.

 

As an example, in November of 2009, in Zhong Nanshan On China’s Death Toll, one of the real heroes of the 2003 SARS epidemic, openly questioned the low number of deaths being reported out of China.

 

The truth is, in many countries, no one was counting the dead. 

 

In South Africa, where nearly 1,000 AIDS/HIV deaths occur each day, no one was looking to see if flu was a factor.  No one had the time, and it simply wasn’t in the budget.  

 

The `official’ death toll, as reported by the World Health Organization was roughly 18,000 deaths globally,  but the WHO offered this disclaimer:

 

The reported number of fatal cases is an under representation of the actual numbers as many deaths are never tested or recognized as influenza related.World Health Organization.

 

Unfortunately, the mainstream media often reported the low official number of deaths without adequately explaining the acknowledged gaps in the data, leading many to believe that the 2009 pandemic was a damp squib.

 

The CDC stopped counting H1N1 influenza deaths in the summer of 2009, realizing that their official tally was more misleading that helpful.

 

In November of that year, they released their first estimate of the number of U.S. pandemic flu infections, hospitalizations, and deaths (see  CDC Releases Revised Hospitalization & Death Estimates), where they estimated that between about 2,500 and 6,000 2009 H1N1-related deaths occurred between April and October 17, 2009.

 

Two months later (see CDC Updates Estimates Of Infections, Hospitalizations, and Deaths From H1N1) the the CDC updated their estimates to carry through to the 12th of December. Their mid-range estimates were of 55 million infections and 11,160 deaths in the US from H1N1 since April of 2009.

 

Today, a study appears in The Lancet that attempts to estimate the number of global H1N1 deaths during the first year of the pandemic, and it comes up with a number than runs between 15 and 30 times higher than reported to the WHO.

Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study

Dr Fatimah S Dawood MD , A Danielle Iuliano PhD, Carrie Reed DSc , Martin I Meltzer PhD , David K Shay MD, Po-Yung Cheng PhD, Don Bandaranayake MBBS , Robert F Breiman MD , W Abdullah Brooks MD , Philippe Buchy MD , Daniel R Feikin MD, Karen B Fowler DrPH , Aubree Gordon PhD , Nguyen Tran Hien MD , Peter Horby MBBSl, Q Sue Huang PhD , Mark A Katz MD , Anand Krishnan MBBS , Renu Lal PhD , Joel M Montgomery PhD , Kåre Mølbak MDo, Richard Pebody MBBS, Anne M Presanis PhD , Hugo Razuri MD , Anneke Steens MSc , Yeny O Tinoco DVM , Jacco Wallinga PhD , Hongjie Yu MDr, Sirenda Vong MD , Joseph Bresee MD , Dr Marc-Alain Widdowson VetMB

Findings

We estimate that globally there were 201 200 respiratory deaths (range 105 700—395 600) with an additional 83 300 cardiovascular deaths (46 000—179 900) associated with 2009 pandemic influenza A H1N1. 80% of the respiratory and cardiovascular deaths were in people younger than 65 years and 59% occurred in southeast Asia and Africa.

 

While most of this report is behind a pay wall, the CDC - which co-authored the study -  has posted a summary on their website.

 

CDC Releases First Global Estimates of 2009 H1N1 Pandemic Mortality

Photo: transparent globe representing the scope of the global estimates used in the CDC study of 2009 H1N1 pandemic mortality.

June 25, 2012 -- A study published today in The Lancet Infectious Diseases Online FirstExternal Web Site Icon provides the first global estimates of how many people died as a result of the 2009 H1N1 influenza pandemic. The study, co-authored by 9 members of the CDC Influenza Division, used an improved modeling approach which resulted in an estimated range of deaths from between 151,700 and 575,400 people who perished worldwide from 2009 H1N1 virus infection during the first year the virus circulated. A disproportionate number of deaths occurred in Southeast Asia and Africa, where access to prevention and treatment resources are more likely to be limited. Study authors hope that this work can be used not only to improve how influenza deaths are estimated, but also to improve the public health response during future pandemics in parts of the world that suffer more influenza-related deaths.

 

These global estimates are more than 15 times higher than the number of laboratory-confirmed deaths reported to the World Health Organization (WHO). WHO has acknowledged for some time that official, lab-confirmed reports are an underestimate of actual number of influenza deaths. Diagnostic specimens are not always collected from people who die with influenza; for others, influenza virus may not be detectable by the time of death. Because of these challenges, modeling is used to estimate the actual burden of disease.

<SNIP>

2009 H1N1 Pandemic Hits the Young Especially Hard

This study estimated that 80% of 2009 H1N1 deaths were in people younger than 65 years of age which differs from typical seasonal influenza epidemics during which 80-90% of deaths are estimated to occur in people 65 years of age and older. To illustrate the impact of the shift in the age distribution of influenza deaths to younger age groups during the pandemic, researchers calculated the number of years of life lost due to 2009 H1N1-associated deaths. They estimated that 3 times as many years of life were lost during the first year of 2009 H1N1 virus circulation than would have occurred for the same number of deaths during a typical influenza season.

(Continue . . . )

 

 

This age shift to younger victims was frequently noted during the pandemic, and in the spring of 2010 a study appeared that found that the mean age of death from the novel H1N1 virus has been calculated to be half that of seasonal flu, or 37.4 years.

 

In terms of years of life lost (YLL), the average pandemic flu death had a many fold greater impact than the average seasonal flu fatality – often robbing decades of potential life from its victims.

 

Preliminary Estimates of Mortality and Years of Life Lost Associated with the 2009 A/H1N1 Pandemic in the US and Comparison with Past Influenza Seasons

By Cecile Viboud, Mark Miller, Don Olson, Michael Osterholm et al (5 authors)

 

 

All of which makes the impact of the 2009 pandemic – in real terms – greater than most people realize.


Today’s new estimate is unlikely to be the last word on this subject. As more data is analyzed and new mathematical models are developed, better estimates will be generated.

 

We’ll never know the true number, of course.  Some things are not directly measureable. But having more accurate estimates can go a long ways towards helping us plan for the next pandemic.

 

And as most researchers acknowledge: that isn’t a matter of `if’, it’s just a matter of `when’.

Wednesday, December 15, 2010

Pandemic Field and Epidemiologic Investigations

 

 

 

# 5145

 

While not terribly severe, the pandemic of 2009 has been perhaps the most intently studied infectious disease outbreak in the history of medical science.

 

Although there is still much to learn, studies conducted over the past 18 months have helped to bring much needed insight to the field of influenza research.

 

Yesterday the CDC, in a press release, announced the availability of more than two dozen research articles in the January, 2011 supplemental issue of Clinical Infectious Diseases.

 

New Articles Highlight the Science Behind Government's Response to 2009 H1N1 Pandemic

For Immediate Release: December 14, 2010
Contact:
CDC Media Relations
(404) 639-3286

WHAT

A series of studies published today in a supplement to the journal Clinical Infectious Diseases (CID) provide a unique look at the science that guided the Federal Government's response to the 2009 H1N1 pandemic.

Topics covered include the impact of the pandemic on society, disease transmission and the effectiveness of mitigation strategies, historical perspectives on the significance of the pandemic compared to prior pandemics, and assessments of preparedness efforts made prior to and following the pandemic.

(Continue . . .)

 

To view the table of contents, and to view the abstracts or complete full texts, follow this link:

 

The 2009 H1N1 Influenza Pandemic: Field and Epidemiologic Investigations

Volume 52 suppl 1 January 1, 2011

 

Cover

 

For an excellent overview, I can think of no better place to start than with last night’s report by  Lisa Schnirring at CIDRAP

 

Studies show science behind CDC pandemic response

Lisa Schnirring * Staff Writer

Dec 14, 2010 (CIDRAP News) – The US Centers for Disease Control and Prevention (CDC) today published a detailed look at the early field and epidemiologic studies it used to guide its response to the 2009 H1N1 pandemic, such as spread among household contacts, disease severity, and the impact on high-risk groups.

 

The 29 reports, all of which are freely available, appear today in an early online supplement of Clinical Infectious Diseases (CID) that is sponsored by the CDC. Topics range from epidemiologic and surveillance methods used by the CDC to clinical characteristics and disease burden.

(Continue . . . )

 

 

 

Since the weather outside has been frightful, I fully expect to spend some quality time over the holidays catching up with my scientific reading – starting with these articles.

Thursday, March 25, 2010

The 1918 – 2009 H1N1 Connection

 

 

 


# 4460

 

Maryn McKenna writing for CIDRAP News has the details of two studies released yesterday that show the similarities between the novel H1N1 virus of 2009 and the pandemic virus of 1918.

 

While sharing the same classification (H1N1) as one of the two seasonal influenza `A’ strains that have been in circulation for decades, novel H1N1 was genetically different enough that those under the age of about 50 had little or no immunity.

 

Now, scientists are beginning to fathom why that is so.

 

This from CIDRAP News.

 

Study shows 1918 and 2009 pandemic viruses share key feature

Maryn McKenna * Contributing Writer

Mar 24, 2010 (CIDRAP News) – Structural similarities between the pandemic flu viruses of 1918 and 2009 may explain older adults' apparent immunity to the newer virus, two scientific teams report today in two journals. Their results may also explain how pandemic viruses evolve into seasonal viruses, and could point the way toward development of future pandemic vaccines.

 

Writing in Science Express, the online ahead-of-print arm of the journal Science, Ian Wilson and Rui Xu of the Scripps Research Institute and colleagues from Vanderbilt University and Mount Sinai School of Medicine say that the 1918 and 2009 pandemic viruses are antigenically close, with hemagglutinin proteins that share similar crystalline structures. In contrast, the hemagglutinins in 24 seasonal flu strains dating from the 1930s through the 1950s, and 9 seasonal-vaccine strains from 1977 through 2007, differed from the pandemic strains by 30% to 58% of their amino-acid sequences.

 

The similarity between the two pandemic viruses is unusual, not only because they are separated by so many years, but also because genetic evidence has shown that the 2009 pandemic virus was not brand-new, but had already been circulating in humans—two circumstances that would have been expected to cause the viruses to diversify as they adapted.

(Continue . . . )

 

 

Helen Branswell, writing for the Canadian Press, also has terrific coverage of this story.  Both reports are well worth reading in their entirety.

 

 

H1N1 virus more like 1918 flu than modern cousins; explains infection patterns

 

Provided by: Canadian Press
Written by: Helen Branswell, Medical Reporter, THE CANADIAN PRESS
Mar. 24, 2010

TORONTO - The pandemic H1N1 virus more closely resembles the 1918 Spanish flu virus than more modern cousins in the same flu family, new research shows - a finding which helps explain the age pattern of H1N1 infections.

 

Like the Spanish flu virus, the pandemic H1N1 lacks two sugar coats seen on contemporary viruses from the same family, the work reveals.

 

The two studies, released Wednesday, confirm that antibodies which protect against the pandemic virus also fight the virus that caused the 1918 pandemic. But they are not able to neutralize seasonal H1N1 viruses, nor are 2009 H1N1 viruses stopped by antibodies generated in response to those recent viruses.

(Continue . . .)